- Planetary alignment peaks with celestial show this weekend
- UK fighters escort Pakistan plane to airport, two arrests
- Judge rules against 'America's toughest sheriff' in racial profiling lawsuit
- Arizona jury foreman says believed Jodi Arias was abused
- Sixth night of violence in Sweden, but police say capital calmer |
FDA approves Bristol Myers, Pfizer's anti-clotting drug Eliquis
Dec 28 (Reuters) - U.S. health regulators approved clot prevention drug Eliquis, developed by Bristol Myers-Squibb Co and Pfizer Inc, for treatment in patients with atrial fibrillation, or irregular heartbeats, not caused by a heart valve problem.
The drug, also known as apixaban, was approved by European health regulators last month.
It should not be taken by patients with prosthetic heart valves or those with atrial fibrillation caused by a heart valve problem, the U.S. Food and Drug Administration said in a statement. 
- Tweet this
- Share this
- Digg this